24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Biotech
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
13:20
SanDisk’s second act: An AI boom, a $160 billion valuation, and a deep Israeli thread
12:52
Zim shareholders approve $4.2 billion sale to Hapag-Lloyd
12:24
Iron Beam and Iron Dome at the frontlines of a quiet Israel-UAE alliance
20:27
Unframe CEO: "I foresaw that enterprises were going to struggle to adopt AI"
More stories
Buzz
Most popular
Daily
Weekly
1
From Iron Dome to Arrow missiles, unpaid bills accumulate in Israel’s defense sector
2
The 50 most promising Israeli startups - 2026
3
Indian Embassy cancels $42 million Tel Aviv office deal at last minute
4
Crypto unicorn MoonPay acquires Israeli security startup Sodot for $100 million
5
The iron gateway to Europe: The connection between German engineering and Israeli audacity
More news
Biotech
20 stories about Biotech
Due to high demand for biotech, Pontifax crosses $1.3 billion funding threshold
12.10.20
|
Tzally Greenberg
A series of successful exits and investments see the Israeli fund balloon by 22% to hit $404 million since the start of the Covid-19 crisis
Biological cancer treatment company Novellus raises $57 million
22.09.20
|
Tzally Greenberg
Novellus develops a drug that delays the development of a BRAF gene mutation created in cases of thyroid cancer and glioma cancer
Immunai Announces $20 Million Seed Round to Fund Immune System Mapping
14.05.20
|
Hagar Ravet
The company employs more than 30 workers in Israel and New York and collaborates with more than 10 world-leading medical centers and bio-pharma companies
Biomed Company CartiHeal Considers a Nasdaq IPO
26.02.20
|
Golan Hazani
The company is looking to raise between $60 million and $80 million according to a valuation of $300 million to $400 million and has already hired Credit Suisse and Jefferies for this purpose, according to two people familiar with the matter
Healthtech Is Israel’s Next Growth Engine, Says Venture Capitalist
21.02.20
|
Sophie Shulman
Yair Schindel was a decorated army medic, a doctor, an entrepreneur, and the head of Israel’s National Digital Bureau. Now, he manages Israeli venture capital fund aMoon and wants to turn Israel into a healthtech empire
Peregrine Ventures Raises Fourth $115 Million Fund
09.12.19
|
CTech
The Israeli medtech venture firm now has over $200 million under management
Steven Mnuchin, Israeli Health Officials Discuss Establishment of Israeli FDA Branch
29.10.19
|
Sophie Shulman
The FDA, which approves all medical devices and formulations in the U.S., has very few branches outside of the U.S.
Teva-Linked Biotech Company 89Bio Files for Nasdaq IPO
15.10.19
|
CTech
Israel and San Francisco-based 89Bio raised a $60 million series A in October 2018
Ophectra Signs Merger Deal With Meat Bioprinting Company MeaTech
03.10.19
|
Ori Galor and Tzally Greenberg
The announcement comes a week after Ophectra announced that its merger deal with cannabis company Hi Pharma fell through
New York-Based Financial Services Firm Jefferies to Join Tel Aviv Stock Exchange
02.06.19
|
Raheli Bindman
As a remote member, Jefferies’ international clients will gain better access to Israeli tech and biotech companies, creating more investment opportunities
RM Global Raises Additional $34 Million for Israel-Based Biopharma Investment Fund
09.04.19
|
CTech
The fund's portfolio is made up of 11 startups operating at the company’s FutuRx biotech accelerator in the central Israeli town of Ness Ziona
Can-Fite BioPharma to Raise $3.2 Million in Direct Offering
04.04.19
|
CTech
The NYSE and Tel Aviv-listed company develops small molecule drugs used in the treatment of liver and inflammatory diseases and cancer
Cell Immunotherapy Company Enlivex Merges With Nasdaq-Listed Bioblast, Raises $5.3 Million
28.03.19
|
Lilach Baumer
The merged entity listed on Nasdaq under the ticker “ENLV”
Anchiano Therapeutics Stock Falls on Nasdaq IPO
13.02.19
|
Lilach Baumer
The cancer treatment company priced its ADSs at $11.5 per unit, expecting proceeds of $30.5 million
Cancer Screening Company Check-Cap Crashes on $7.5 Million Nasdaq Direct Offering
05.02.19
|
Lilach Baumer
The clinical-stage company announced the discounted offering Monday, closing 27.62% down on the exchange
Pfizer Taps Israeli Machine Learning Drug Discovery Company CytoReason
10.01.19
|
Lilach Baumer
Under the agreement, CytoReason will receive payments "potentially equaling up to low double digit millions" of dollars
Celgene Backs Immunotherapy Company Biond Biologics
08.01.19
|
Meir Orbach
Biond develops immunotherapies for cancer and autoimmune diseases
Novartis Invests $10 Million in Anti-Cancer Company Ayala Pharmaceuticals
24.12.18
|
Lilach Baumer
The investment is part of a licensing option agreement signed between the two companies
Lonza Opens Israeli Innovation Center
20.11.18
|
Lilach Baumer
The company announced plans for the center in 2017, stating it is looking to tap Israel's tech talent
Israeli and French Biotech Companies Partner to Fight Diabetes With Bio-Artificial Pancreas
12.11.18
|
Lilach Baumer
Israel-based Kadimastem and France-headquartered Defymed will receive a grant of around $1.5 million from the European Commission's Eurostars program to develop the technology to treat type 1 diabetes
Previous Articles
More Articles